109 related articles for article (PubMed ID: 30731053)
1. Effects of Species-Specific Genetics on Alzheimer's Mouse Models.
Hyman B; Tanzi RE
Neuron; 2019 Feb; 101(3):351-352. PubMed ID: 30731053
[TBL] [Abstract][Full Text] [Related]
2. Harnessing Genetic Complexity to Enhance Translatability of Alzheimer's Disease Mouse Models: A Path toward Precision Medicine.
Neuner SM; Heuer SE; Huentelman MJ; O'Connell KMS; Kaczorowski CC
Neuron; 2019 Feb; 101(3):399-411.e5. PubMed ID: 30595332
[TBL] [Abstract][Full Text] [Related]
3. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
4. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
5. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
6. Genetic mouse models of Alzheimer's disease.
Mineur YS; McLoughlin D; Crusio WE; Sluyter F
Neural Plast; 2005; 12(4):299-310. PubMed ID: 16444901
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: transgenic mouse models and drug assessment.
Yu P; Oberto G
Pharmacol Res; 2000 Aug; 42(2):107-14. PubMed ID: 10887038
[TBL] [Abstract][Full Text] [Related]
9. Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD.
Mucke L; Pitas RE
Neuron; 2004 Sep; 43(5):596-9. PubMed ID: 15339638
[TBL] [Abstract][Full Text] [Related]
10. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
[TBL] [Abstract][Full Text] [Related]
11. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
Kent BA; Strittmatter SM; Nygaard HB
J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
Pietropaolo S; Feldon J; Yee BK
Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
[TBL] [Abstract][Full Text] [Related]
14. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.
Plagg B; Marksteiner J; Kniewallner KM; Humpel C
Biogerontology; 2015 Aug; 16(4):543-58. PubMed ID: 25947203
[TBL] [Abstract][Full Text] [Related]
15. The bad seed in Alzheimer's disease.
Fryer JD; Holtzman DM
Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease.
Koppel J; Jimenez H; Azose M; D'Abramo C; Acker C; Buthorn J; Greenwald BS; Lewis J; Lesser M; Liu Z; Davies P
Behav Brain Res; 2014 Dec; 275():27-33. PubMed ID: 25151619
[TBL] [Abstract][Full Text] [Related]
17. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
18. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
[TBL] [Abstract][Full Text] [Related]
20. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
